To the content
3 . 2014

The efficiency of DPP-4 inhibitors in combination with metformin in patients with diabetes mellitus type 2 and obesity

Abstract

Complex nature of diabetes mellitus suggests further immersion in her study and fundraising timely feedback. The article presents the results of a study showing that in patients with diabetes mellitus type 2 who have not reached the target values of glycemia on metformin monotherapy, the use of fixed-dose combination sitagliptin + metformin achieves expressed improvement in glycemic control and indicators of fat metabolism.

Keywords:inhibitors of DPP-4, fat metabolism, glucose toxicity, lipotoxicity

Endocrinology: News, Opinions, Training. 2017; (3): 88–92.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
CHIEF EDITOR
Ametov Alexander S.
Honored Scientist of the Russian Federation, Doctor of Medical Sciences, Professor, Head of Subdepartment of Endocrinology, Head of the UNESCO Network Chair on the subject «Bioethics of diabetes as a global problem» of the Russian Medical Academy of Continuous Professional Education (Moscow)
Вскрытие

Journals of «GEOTAR-Media»